An investigational drug-eluting stent called Xience, coated with everolimus, led to significantly less late lumen loss after nine months than did the Taxus (paclitaxel-eluting) stent, said researchers here today. March 2007
M. Anđelović. University of Zagreb. Faculty of Humanities and Social Sciences. Department of Archaeology, info:eu-repo/semantics/masterThesis, (February 2021)